HalluDesign-NA: New Framework Extends AI-Powered Nucleic Acid Design Capabilities
Researchers have extended the HalluDesign framework to enable de novo design of nucleic acids, including ssDNA, ssRNA, and aptamers, by integrating AlphaFold3 with a sequence optimization tool called NA-MPNN. The system performs iterative sequence-structure co-optimization and was benchmarked across multiple nucleic acid design tasks, showing consistent improvements in structural confidence metrics. The work could accelerate development of engineered nucleic acids for biotechnology and medical applications.
A research team has introduced HalluDesign-NA, an extension of the existing HalluDesign computational framework, designed to tackle the de novo design of structured and functional nucleic acids. The approach leverages AlphaFold3—which has enabled atomic-level modeling of nucleic acid structures and interactions—combined with NA-MPNN, a tool for nucleic acid sequence optimization. Together, these components enable iterative co-optimization of sequence and structure, allowing researchers to design nucleic acids under various constraints including sequence length, symmetry, and protein structural context. Computational benchmarking on single-stranded DNA, single-stranded RNA, and aptamer design tasks demonstrated consistent improvements in confidence scores such as pLDDT and ipTM, standard metrics used to assess predicted structural quality. While the results are currently computational, the authors argue they support the feasibility of de novo nucleic acid design. The source code has been made publicly available on GitHub, facilitating adoption by the broader research community. The authors anticipate the framework will find use in designing functional nucleic acids for therapeutic and biotechnological purposes.
What's missing
As a preprint posted on bioRxiv, this work has not yet undergone peer review, and its findings should be interpreted with appropriate caution. The study relies entirely on computational benchmarking; no experimental wet-lab validation of the designed nucleic acid sequences is reported, leaving open the question of whether computationally optimized sequences fold and function as predicted in vitro or in vivo. The relationship between the confidence metrics used (pLDDT, ipTM) and actual biological functionality of designed nucleic acids is not fully established.
What different sources said
- bioRxivCenter
HalluDesign-NA: Extending HalluDesign for De Novo Nucleic Acid Design
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.